Expertise in
3
conditions

Dr. Daniel Lorch

Pulmonary Medicine
Pulmonary Associates
4051 Upper Creek Dr Ste 106, 
Sun City Center, FL 
Expertise in
3
conditions
Pulmonary Associates
4051 Upper Creek Dr Ste 106, 
Sun City Center, FL 

Overview

Daniel Lorch is a Pulmonary Medicine provider practicing medicine in Sun City Center, Florida.

Dr. Lorch is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Lung Metastases, Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Bronchiectasis, and Advanced Bronchoscopy.

He is actively involved in clinical research, co-authoring 7 peer reviewed articles and participating in 8 clinical trials.

Specialties

Pulmonary Medicine

Licenses

Internal Medicine in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

Pulmonary Associates
4051 Upper Creek Dr Ste 106, Sun City Center, FL 33573
Other Locations
Pulmonary Associates Of Brandon
1723 S Kings Ave, Brandon, FL 33511

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Master Protocol to Investigate the Efficacy and Safety of Tirzepatide Once Weekly in Participants Who Have Obstructive Sleep Apnea and Obesity: A Randomized, Double-Blind, Placebo-Controlled Trial
A Master Protocol to Investigate the Efficacy and Safety of Tirzepatide Once Weekly in Participants Who Have Obstructive Sleep Apnea and Obesity: A Randomized, Double-Blind, Placebo-Controlled Trial
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
Enrollment Status: Completed
Publish Date: June 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19
A Phase 2, Open Label, Randomized Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) With Standard of Care Versus Standard of Care in Subjects Hospitalized With COVID-19
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug, Other
Study Drug: Abivertinib
Study Phase: Phase 2
Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: December 12, 2022
Intervention Type: Drug
Study Drugs: AD109, AD504, Atomoxetine Hydrochloride
Study Phase: Phase 2
A Randomized, Blinded-controlled Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adult Patients With COVID-19
A Randomized, Blinded-controlled Study to Evaluate the Safety and Efficacy of a Single Dose of STI-2020 (COVI-AMG™) in Hospitalized Adult Patients With COVID-19
Enrollment Status: Withdrawn
Publish Date: August 16, 2022
Intervention Type: Drug, Biological
Study Drug: COVI-AMG COVID-19 Vaccine
Study Phase: Phase 2
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
A Randomized, Placebo-Controlled, Double-blind, Fixed-Dose, Multiple Cohort, Multiple Crossover, Dose-Finding Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (IH) or Narcolepsy Type 2
Enrollment Status: Completed
Publish Date: January 16, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

7 Total Publications

Respiratory safety of lemborexant in adult and elderly subjects with moderate-to-severe chronic obstructive pulmonary disease.
Respiratory safety of lemborexant in adult and elderly subjects with moderate-to-severe chronic obstructive pulmonary disease.
Journal: Journal of sleep research
Published: May 02, 2024
Similar Doctors
Expertise in
18
conditions
Dr. Naishadh K. Mandaliya
Pulmonary Medicine | Intensive Care Medicine | Internal Medicine
Expertise in
18
conditions
Dr. Naishadh K. Mandaliya
Pulmonary Medicine | Intensive Care Medicine | Internal Medicine
Referral may be required

Tampa Bay Pulmonary Associates, PA

6901 Simmons Loop, Ste 207, 
Riverview, FL 
 (10.5 miles away)
813-935-5501
Languages Spoken:
English, Hindi
See accepted insurances
Offers Telehealth

Naishadh Mandaliya is an Internal Medicine specialist and an Intensive Care Medicine provider practicing medicine in Riverview, Florida. Dr. Mandaliya is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Lung Metastases, Hospital-Acquired Pneumonia, Gastrostomy, and Advanced Bronchoscopy. Dr. Mandaliya is board certified in AB Internal Medicine - Internal Medicine, AB Internal Medicine (Critical Care Medicine), and AB Internal Medicine (Pulmonary Disease).

Expertise in
28
conditions
Dr. Ivan F. Ackerman
Pulmonary Medicine | Sleep Medicine | Internal Medicine
Expertise in
28
conditions
Dr. Ivan F. Ackerman
Pulmonary Medicine | Sleep Medicine | Internal Medicine
Referral may be required

Tampa Bay Pulmonary Medicine, PA

402 Noland Dr, 
Brandon, FL 
 (0.4 miles away)
813-655-2500
Languages Spoken:
English
See accepted insurances

Ivan Ackerman is an Internal Medicine specialist and a Sleep Medicine provider practicing medicine in Brandon, Florida. Dr. Ackerman is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Lung Metastases, Drowsiness, and Excessive Daytime Sleepiness. Dr. Ackerman is board certified in AB Internal Medicine - Internal Medicine, AB Internal Medicine (Pulmonary Disease), and AB Internal Medicine (Sleep Medicine).

Expertise in
26
conditions
Dr. Rajesh K. Agrawal
Pulmonary Medicine
Expertise in
26
conditions
Dr. Rajesh K. Agrawal
Pulmonary Medicine
Referral may be required

American Lung & Sleep Disorders Consultants PA

6223 66th St N, 
Pinellas Park, FL 
 (27.3 miles away)
727-528-4900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rajesh Agrawal is a Pulmonary Medicine provider practicing medicine in Pinellas Park, Florida. Dr. Agrawal is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Bronchitis, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Gastrostomy, and Endoscopy. Dr. Agrawal is board certified in American Board Of Internal Medicine. Dr. Agrawal is currently accepting new patients.

Frequently Asked Questions about Dr. Daniel Lorch

Is Dr. Daniel Lorch a top-rated expert for Lung Metastases?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Daniel Lorch is classified as an Advanced expert for Lung Metastases, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Daniel Lorch specialize in?

While Dr. Daniel Lorch is a Pulmonary Medicine, they have specific expertise in Lung Metastases, Obstructive Sleep Apnea, and Chronic Obstructive Pulmonary Disease (COPD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Daniel Lorch participate in research or clinical trials?

Yes. Dr. Daniel Lorch has published 7 articles and abstracts on conditions like Lung Metastases. You can view a list of Dr. Daniel Lorch's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Daniel Lorch accept my insurance?

Dr. Daniel Lorch accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Lorch's expertise for a condition
ConditionClose
      View All 37 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile